ロード中...

Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway

It is generally known that glioblastoma is the most common primary malignant brain tumor and that it is highly aggressive and deadly. Although surgical and pharmacological therapies have made long-term progress, glioblastoma remains extremely lethal and has an uncommonly low survival rate. Therefore...

詳細記述

保存先:
書誌詳細
出版年:Oncol Rep
主要な著者: Ke, Xiao-Xue, Pang, Yi, Chen, Kuijun, Zhang, Dunke, Wang, Feng, Zhu, Shunqin, Mao, Jingxin, Hu, Xiaosong, Zhang, Guanghui, Cui, Hongjuan
フォーマット: Artigo
言語:Inglês
出版事項: D.A. Spandidos 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196630/
https://ncbi.nlm.nih.gov/pubmed/30542699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6777
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!